UK-specific guidance for the application and management of clinical trials in the context of COVID-19
The UK’s MHRA has stated it will be particularly flexible and pragmatic in authorising clinical trials connected to COVID-19, referring to its previous track record of having acted swiftly in past public health crises
A recent decision by the English courts has confirmed that litigation privilege is available for criminal investigations
The Court of Appeal has refused an appeal by victims of post-election violence in Kenya to impose liability on the parent company of the tea plantation where they worked.
Select Committee of the Upper House makes recommendations for the UK to realise its AI potential.